Home
Jeffrey W. Albers, Director: Kymera Therapeutics KYMR Sell · Filed 25/12/08
Trade details
- Type
- Insider sale
- Amount
- $245,451.36
- Shares · price
- 2,748 sh · $89.32 a share
- Held after
- 2,252 sh
- Trade date
- 25/12/08
- Filed
- 25/12/08
- Days to filing
- 0 days
Sold 55.0% of holdings
- Share of holding sold
- 55.0%
Kymera Therapeutics trades, last 26 weeks
What else happened in Kymera Therapeutics around then
Filed or reported within 30 days of the trade day · 25/11/08~01/07Jeffrey W. Albers's recent trades
- Jeffrey W. Albers
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 planSpyre Therapeutics
SYRE
$517.1K
5,000 sh
$517.1K
Filed 08/07
Traded 08/07
- Jeffrey W. Albers
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 planSpyre Therapeutics
SYRE
$1.9M
18,000 sh
$1.9M
Filed 08/07
Traded 08/07
- Jeffrey W. Albers
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 planKymera Therapeutics
KYMR
$203.4K
2,252 sh
$203.4K
Filed 25/12/08
Traded 25/12/08
- Jeffrey W. Albers
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 planKymera Therapeutics
KYMR
$333.1K
5,000 sh
$333.1K
Filed 25/12/08
Traded 25/12/08
- Jeffrey W. Albers
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 planKymera Therapeutics
KYMR
$296K
5,000 sh
$296K
Filed 25/10/14
Traded 25/10/13
